Skip to content

Effect of combined dexamethasone and dexmedetomidine on rebound pain after nerve block in patients undergoing upper limb fracture surgery

Effect of combined dexamethasone and dexmedetomidine on rebound pain after nerve block in patients undergoing upper limb fracture surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108452
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rebound pain after nerve block in patients with upper limb fractures

Interventions

Control group:Intravenous dexamethasone
Experimental group:Intravenous dexamethasone combined with intravenous pump dexmedetomidine

Sponsors

Chongqing Dazu District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients with upper extremity fractures who are scheduled to undergo postoperative analgesia with a single interscalene brachial plexus block 2.American Society of Anesthesiologists (ASA) grade I–III 3.Age >= 18 years old and <= 75 years old 4.18.5<=BMI<=30kg/m^2 5.Able to understand the Numeric Pain Rating Scale (NRS) and give feedback.

Exclusion criteria

Exclusion criteria: 1.Severe hematological diseases or abnormal coagulation function 2. Previous peripheral nerve and muscle lesions 3.Infection at the puncture site 4. Allergy to the trial drug or local anesthetics 5. Long-term use of glucocorticoids and a2 adrenergic receptor agonists 6. Sinus bradycardia (heart rate <45 beats/min), grade II or III atrioventricular block, NYHA cardiac function class III or IV 7. Cognitive impairment 8. Nerve block failure and NRS score = 4 points in the post-anesthesia care unit (PACU).

Design outcomes

Primary

MeasureTime frame
Incidence of rebound pain;

Secondary

MeasureTime frame
Rebound pain occurs when and lasts;Pain score at rest, during exertion;Opioid consumption;Postoperative nausea and vomiting;Sleep quality score;

Countries

China

Contacts

Public ContactJinyan Pan

Chongqing Dazu District People's Hospital

1083414335@qq.com+86 188 8336 4805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026